How To Speed Up MLR Reviews, Cut Risk: A Master Class By J&J, UCB, ex-Takeda Heads

Regulators Need To Catch Up

A panel of experts from J&J, UCB and Takeda deliberated on the use of AI and internal processes to strike the right balance between speed and accuracy in MLR reviews that could protect a company from serious repercussions. They also spoke of the need for regulatory systems to catch up.

Speakers from J&J, UCB And Takeda On The MLR Review Panel At Indegene Digital Summit 2024
Speakers On The MLR Review Panel At Indegene Digital Summit 2024 (Indegene)

Be quick or be safe? That’s a dilemma the pharmaceutical industry faces often as it seeks to bring a new drug to any market.

A panel of medical, legal, regulatory (MLR) review experts, including an ex-Takeda head and present heads of Johnson & Johson and UCB, deliberated on the issue at Indegene’s Digital Summit,...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Marketing & Advertising

More from Pathways & Standards